NY settles FCA claims with KV, Dava Pharma; Baxter gets European nod for flu vax;

@FiercePharma: China's health minister scolds hospitals for profiting off high-priced drugs--Reuters. News | Follow @FiercePharma

> New York's attorney general said KV Pharmaceutical and Dava Pharmaceuticals will pay the state a total of $28 million in separate False Claims Act settlements. More

> Baxter International ($BAX) won European approval for its flu vaccine Vepacel. Report

> Indian pharmaceutical companies are complaining about their country's drug procurement process and are calling for an open tender approach combining supplies of branded and generic drugs. Story

> The U.S. Senate killed a Republican effort to allow employers and insurers to deny coverage for contraceptives and other treatments they object to for religious or moral reasons. Article

> Novartis ($NVS) launched its blood pressure drugs Galvus and Exforge HCT in Ghana. News

> Watson Pharma ($WPI) introduced its version of Abbott Laboratories' ($ABT) hormone drug Prometrium under an agreement with the branded drugmaker. Report

Biotech News

@FierceBiotech: Social media jump-starts stalled patient recruitment efforts. Piece | Follow @FierceBiotech

@JohnCFierce: GSK's Witty confident the co. will be rewarded for big R&D investment in China. Translation: They won't get stiffed. Article | Follow @JohnCFierce

@RyanMFierce: NCI's cancer informatics group says goodbye to chief after program stalls. News via @bioitworld. Story | Follow @RyanMFierce

@FierceMedDev: Youngstown News, New motion-sensor technology eases debilitating pain of Boardman man. News via @vindicator. Story | Follow @FierceMedDev

> Company 'insiders' nabbed 43% of Verastem's IPO offering. More

> High Ph3 placebo response complicates Lundbeck's case for anti-drinking drug. Article

Medical Device News

> Mouth sensor, iPhone boost quadriplegics' mobility. Item

> Structural heart disease devicemaker lands $250K in seed money. News

> Australia's TGA slammed for device safety oversight. Article

> Families sue Synthes, former execs over deaths in bone cement case. Story

IT News

> Aptiv marries IT and CRO services to tackle adaptive trials market. Story

> NIH backs effort to integrate clinical trials data into EHRs. Article

> Social media jump-starts stalled patient recruitment efforts. Item

And Finally... Merck ($MRK) says it will ask the FDA to approve allergy pills for ragweed and grass reactions as an alternative to traditional immunotherapy. Article

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.